Articles / Evidence & trends

Buying health technology from a small company: what to ask first

It is the question nobody asks in the meeting and everybody thinks: what if you go under? It deserves a serious answer, and it is easier to give when we raise it ourselves.

Topic
Evidence & trends
Read
8 min read
Published
31 August 2026
Author
Pedro Thomaz
Scope
Base product · Class I

On this page

The European digital health market is growing and, at the same time, concentrating: capital goes to fewer and larger companies, and underneath sits a long tail of small suppliers. We are one of them.

That creates a risk that rarely appears in a specification and belongs entirely to the institution: the equipment stays, the supplier may not.

Better to discuss it head on than to hope nobody asks.

Why this differs from other sectors

If a chair supplier closes, the chairs remain chairs. In software and connected equipment, a product can stop working without anyone touching it: a licence that expires, a server that shuts down, an app store that stops serving the app.

The right question is not "are you solid?", everyone says yes. It is:

What keeps working on the day you disappear?

Who does what: RVer and the institution A table of responsibilities. Equipment: RVer owns, maintains and replaces it; the institution uses it and never buys it. Content: RVer supplies the validated library and the updates; the institution chooses what to use and with whom. Training: RVer trains the team; the institution frees up the people. Session: RVer records it; the institution runs and accompanies it. Data: RVer keeps no copy of usage data; the institution is the data controller. Clinical decision: RVer has no part in it; the institution has all of it. RVer Institution Equipment Ours. We maintain and replace it. Uses it. Never buys it. Content Validated library and updates. Chooses what to use, and with whom. Training We train the team. Frees up the people. Session Records what happened. Runs and accompanies it. Data We keep no copy. Is the data controller. Clinical decision None. All of it. RVer records; reading it and deciding belong to the team.
How responsibilities split between RVer and the institution, from the equipment to the clinical decision.

The seven questions

They apply to any small health technology supplier:

  1. Does the product work without your servers? If the answer is no, you are buying a subscription to a service, not equipment.
  2. Does it need internet for normal use?
  3. If the company disappears, what exactly stops working, and when?
  4. Is data exportable in an open format, without asking you for anything?
  5. Who can repair or replace the hardware other than you?
  6. What does the contract provide for on termination, insolvency or acquisition?
  7. How many people can keep this running? If it is one, it is a person, not a company.

Our answers, including the ones that do not favour us

What keeps working without us:

  • Playback of already installed content. The scenarios sit on the device and run without internet. A headset with the library installed keeps running sessions.
  • Control from the browser, because it runs on the institution's local network, not our cloud.
  • The hardware. The equipment is commercial and unmodified by us; it is not bricked.

What stops working:

  • New content. The catalogue is generated from our backoffice. Without us, the library freezes at whatever is installed.
  • Updates to the application, fixes and new features.
  • Support, training and replacement of faulty equipment under contract.
  • Modules in development, which are already outside the medical device registration and should not weigh in a purchase decision.

Plainly: sessions continue, evolution stops. That is a better answer than many products that need a cloud to function at all, and a worse one than "nothing changes", which would not be true.

What an institution can require by contract

None of this is exotic and most suppliers accept it, if asked:

  • Data export in an open format, on request and at no cost.
  • Notice period on discontinuation of service.
  • A continuity clause guaranteeing continued use of what is installed.
  • Operating documentation sufficient for someone else to understand the system.

If a supplier refuses the first one, that is a signal in itself.

The other side, which is also honest

Large companies discontinue products just as readily: only without warning and with nobody to talk to. "Buy from the biggest" reduces insolvency risk and increases irrelevance risk: a small product inside a large company is the first thing cut in a reorganisation.

What genuinely reduces risk is not supplier size. It is the architecture (does it work without them?) and the contract.

In short

  • The equipment stays, the supplier may not, and the risk is the institution's.
  • The question is what keeps working, not whether the supplier is solid.
  • With us: sessions continue (installed content, local network, commercial hardware) and evolution stops (new content, updates, support).
  • Require data export and a continuity clause. Whoever refuses is answering you.
  • Buying from the biggest trades one risk for another, it does not remove it.

Frequently asked questions

What happens to the equipment if the supplier closes?

It depends entirely on the architecture. With RVer, playback of already installed content keeps working because the scenarios sit on the device and run without internet, browser control keeps working because it runs on the institution's local network, and the hardware is commercial and unmodified. What stops is new content, which is generated from our backoffice, plus updates, support and equipment replacement.

What should you ask a small supplier before buying?

Whether the product works without the supplier's servers, whether it needs internet for normal use, what exactly stops working if the company disappears, whether data is exportable in an open format without asking permission, who can repair the hardware other than the supplier, what the contract provides for on termination or insolvency, and how many people can keep the system running.

Is it safer to buy from a large company?

It trades one risk for another. It reduces insolvency risk and increases discontinuation risk: a small product inside a large company is usually the first thing cut in a reorganisation, often without warning and with nobody to talk to. What genuinely reduces risk is the product architecture and what the contract says, not the size of whoever sells it.

A concrete case?

Tell us what the situation is

We answer yes, “it needs testing”, or no. All three happen, and the last one is useful too.

Request a proposal →

← Back to the articles